120 related articles for article (PubMed ID: 12624602)
21. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
23. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro.
Liu J; Wang X; Wang F; Teng L; Cao J
Biomed Pharmacother; 2009 Aug; 63(7):484-91. PubMed ID: 18602243
[TBL] [Abstract][Full Text] [Related]
24. [A preliminary study of CTGF in bleomycin-induced mouse pulmonary fibrosis].
Zhang L; Lu HP; Lai GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):290-2. PubMed ID: 15862142
[TBL] [Abstract][Full Text] [Related]
25. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
[TBL] [Abstract][Full Text] [Related]
26. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
Pass HI; Brewer GJ; Dick R; Carbone M; Merajver S
Ann Thorac Surg; 2008 Aug; 86(2):383-9; discussion 390. PubMed ID: 18640301
[TBL] [Abstract][Full Text] [Related]
27. Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Brewer GJ
Drug Discov Today; 2005 Aug; 10(16):1103-9. PubMed ID: 16182195
[TBL] [Abstract][Full Text] [Related]
28. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
Khan MK; Mamou F; Schipper MJ; May KS; Kwitny A; Warnat A; Bolton B; Nair BM; Kariapper MS; Miller M; Brewer G; Normolle D; Merajver SD; Teknos TN
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):333-8. PubMed ID: 16549755
[TBL] [Abstract][Full Text] [Related]
29. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
Kalayarasan S; Sriram N; Sudhandiran G
Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin.
Oury TD; Thakker K; Menache M; Chang LY; Crapo JD; Day BJ
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):164-9. PubMed ID: 11509325
[TBL] [Abstract][Full Text] [Related]
31. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats.
Gong LK; Li XH; Wang H; Zhang L; Chen FP; Cai Y; Qi XM; Liu LL; Liu YZ; Wu XF; Huang CG; Ren J
J Ethnopharmacol; 2005 Jan; 96(3):537-44. PubMed ID: 15619575
[TBL] [Abstract][Full Text] [Related]
32. The copper chelator tetrathiomolybdate regressed bleomycin-induced pulmonary fibrosis in mice, by reducing lysyl oxidase expressions.
Ovet H; Oztay F
Biol Trace Elem Res; 2014 Dec; 162(1-3):189-99. PubMed ID: 25349139
[TBL] [Abstract][Full Text] [Related]
33. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats.
Sogut S; Ozyurt H; Armutcu F; Kart L; Iraz M; Akyol O; Ozen S; Kaplan S; Temel I; Yildirim Z
Eur J Pharmacol; 2004 Jun; 494(2-3):213-20. PubMed ID: 15212977
[TBL] [Abstract][Full Text] [Related]
34. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.
Manoury B; Nenan S; Leclerc O; Guenon I; Boichot E; Planquois JM; Bertrand CP; Lagente V
Respir Res; 2005 Jan; 6(1):11. PubMed ID: 15663794
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity to bleomycin-induced lung injury is not moderated by an antigen-limited T-cell repertoire.
Thatcher TH; Sime PJ; Barth RK
Exp Lung Res; 2005 Sep; 31(7):685-700. PubMed ID: 16203623
[TBL] [Abstract][Full Text] [Related]
36. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats.
Yildirim Z; Kotuk M; Erdogan H; Iraz M; Yagmurca M; Kuku I; Fadillioglu E
J Pineal Res; 2006 Jan; 40(1):27-33. PubMed ID: 16313495
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
38. Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate.
Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2009 Jun; 234(6):662-5. PubMed ID: 19307461
[TBL] [Abstract][Full Text] [Related]
39. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
40. An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model.
Nishimoto T; Mlakar L; Takihara T; Feghali-Bostwick C
Int Immunopharmacol; 2015 Oct; 28(2):1102-5. PubMed ID: 26315492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
